(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-30 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 221650
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Mon Sep 2024 | 8.06 | 8.07 | 8.15 | 8.02 | 1.084 times |
| 27 Fri Sep 2024 | 8.10 | 8.12 | 8.15 | 8.05 | 0.735 times |
| 26 Thu Sep 2024 | 8.06 | 7.96 | 8.12 | 7.93 | 0.694 times |
| 25 Wed Sep 2024 | 7.96 | 8.05 | 8.05 | 7.90 | 0.81 times |
| 24 Tue Sep 2024 | 8.02 | 7.97 | 8.11 | 7.88 | 1.077 times |
| 23 Mon Sep 2024 | 7.94 | 8.07 | 8.08 | 7.93 | 0.996 times |
| 20 Fri Sep 2024 | 8.01 | 8.20 | 8.23 | 7.99 | 2.928 times |
| 19 Thu Sep 2024 | 8.21 | 8.38 | 8.38 | 8.21 | 0.555 times |
| 18 Wed Sep 2024 | 8.27 | 8.29 | 8.42 | 8.21 | 0.778 times |
| 17 Tue Sep 2024 | 8.24 | 8.19 | 8.33 | 8.14 | 0.773 times |
My analysis of stock is bearish for shortterm, and stock might move down till 8 or till 7.9. Use a stoploss of 8.08 and if the stock hits stoploss, then it can shoot up till 8.17
Share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Target | 7.44 |
| Downside Target | 7.88 |
| Upside Target | 8.20 |
| Upside Target | 8.24 |
| Upside Target | 8.28 |
| Upside Target | 8.42 |
| Upside Target | 9.01 |
| Upside Target | 10.22 |
| Upside Target | 10.37 |
| Upside Target | 10.42 |
Intraday share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Intraday Target | 8 |
| Downside Intraday Target | 7.95 |
| Upside Intraday Target | 8.13 |
| Upside Intraday Target | 8.21 |
| Upside Intraday Target | 8.08 |
Weekly technical analysis of Theravance Biopharma (TBPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Mon Sep 2024 | 8.06 | 8.07 | 8.15 | 8.02 | 0.251 times |
| 27 Fri Sep 2024 | 8.10 | 8.07 | 8.15 | 7.88 | 0.758 times |
| 20 Fri Sep 2024 | 8.01 | 8.19 | 8.42 | 7.99 | 1.216 times |
| 13 Fri Sep 2024 | 8.14 | 8.03 | 8.20 | 7.90 | 1.284 times |
| 06 Fri Sep 2024 | 8.01 | 8.18 | 8.24 | 7.94 | 3.405 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Mon Sep 2024 | 8.06 | 8.18 | 8.42 | 7.88 | 0.378 times |
| 30 Fri Aug 2024 | 8.25 | 10.16 | 10.22 | 7.44 | 1.459 times |
| 31 Wed Jul 2024 | 10.11 | 8.46 | 10.42 | 8.19 | 1.048 times |
| 28 Fri Jun 2024 | 8.48 | 8.68 | 9.01 | 8.28 | 0.833 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.